Level Biotechnology Financials
| 3118 Stock | TWD 32.10 0.05 0.16% |
Level |
Understanding current and past Level Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Level Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Level Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Level Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Level Biotechnology. Check Level Biotechnology's Beneish M Score to see the likelihood of Level Biotechnology's management manipulating its earnings.
Level Biotechnology Stock Summary
Level Biotechnology competes with Oneness Biotech, Medigen Vaccine, OBI Pharma, TaiMed Biologics, and Tanvex BioPharma. Level Biotechnology Inc. markets and distributes cell culture, immunology, molecular biology products and biomedical precision equipment in Taiwan. The company was founded in 1989 and is headquartered in New Taipei City, Taiwan. LEVEL BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 122 people.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0003118006 |
| Business Address | No 80, Kangning |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.level.com.tw |
| Phone | 886 2 2695 9935 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Level Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Level Stock, because this is throwing your money away. Analyzing the key information contained in Level Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Level Biotechnology Key Financial Ratios
There are many critical financial ratios that Level Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Level Biotechnology reports annually and quarterly.| Return On Equity | 0.11 | |||
| Return On Asset | 0.0519 | |||
| Number Of Employees | 121 | |||
| Beta | 0.56 | |||
| Z Score | 30.6 |
Level Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Level Biotechnology's current stock value. Our valuation model uses many indicators to compare Level Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Level Biotechnology competition to find correlations between indicators driving Level Biotechnology's intrinsic value. More Info.Level Biotechnology is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Level Biotechnology is roughly 2.08 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Level Biotechnology's earnings, one of the primary drivers of an investment's value.Level Biotechnology Systematic Risk
Level Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Level Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Level Biotechnology correlated with the market. If Beta is less than 0 Level Biotechnology generally moves in the opposite direction as compared to the market. If Level Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Level Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Level Biotechnology is generally in the same direction as the market. If Beta > 1 Level Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Level Biotechnology Thematic Clasifications
Level Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Level Biotechnology November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Level Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Level Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Level Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Level Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Level Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 3.74 | |||
| Value At Risk | (1.09) | |||
| Potential Upside | 1.08 |
Additional Tools for Level Stock Analysis
When running Level Biotechnology's price analysis, check to measure Level Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Level Biotechnology is operating at the current time. Most of Level Biotechnology's value examination focuses on studying past and present price action to predict the probability of Level Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Level Biotechnology's price. Additionally, you may evaluate how the addition of Level Biotechnology to your portfolios can decrease your overall portfolio volatility.